3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Polycystic Ovary Syndrome
3
Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Venous Thromboembolism
1
Tuberous Sclerosis
1
Thrombosis
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Perioperative Inflammatory Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Margins of Excision
1
Lymphangioleiomyomatosis
1
Interventions
Everolimus
12
Sirolimus
10
Cannabidiol
3
ganaxolone
2
Melatonin
2
Activator Appliances
2
radiprodil
1
Vigabatrin
1
Urination
1
Simvastatin
1
Propranolol
1
Doxycycline
1
Calcitriol
1
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Tuberous Sclerosis
×
Simvastatin
×
Clear all
NCT02061397
2020-08-25
SOS
University of Pennsylvania
Phase 1/2
Completed
10 enrolled
6 charts